GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (FRA:XE7C) » Definitions » Net Interest Margin (Bank Only) %

Cardiff Oncology (FRA:XE7C) Net Interest Margin (Bank Only) %


View and export this data going back to 1997. Start your Free Trial

What is Cardiff Oncology Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.


Cardiff Oncology Business Description

Industry
Traded in Other Exchanges
Address
11055 Flintkote Avenue, San Diego, CA, USA, 92121
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.